Small hypervascular hepatocellular carcinomas: Value of "washout" on gadolinium-enhanced dynamic MR imaging compared to superparamagnetic iron oxide-enhanced imaging

European Radiology

Volumn 19, Issue 11, 2009, Pages 2614-2622

  Yu, Jeong Sik ^a   Chung, Jae Joon ^a   Kim, Joo Hee ^a   Kim, Ki Whang ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Gadolinium; Hepatocellular carcinoma; Iron; Liver cirrhosis; MR imaging

Indexed keywords

FERUCARBOTRAN; GADOLINIUM; GADOLINIUM PENTETATE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG UPTAKE; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SMALL HYPERVACULAR LIVER CELL CARCINOMA; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEMALE; FERRIC COMPOUNDS; FIBROSIS; GADOLINIUM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 70350169821     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1465-8     Document Type: Article

References (35)

1. Murakami T, Kim T, Nakamura M (1998) Hepatitis, cirrhosis and hepatoma. J Magn Reson Imaging 8:346-358
2. Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS (2005) Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 11:281-289
3. Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 35:421-430
4. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatology 42:1208-1236
5. Seneterre E, Taourel P, Bouvier Y et al (1996) Detection of hepatic metastases: Ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200:785-792
6. Choi D, Kim SH, Lim JH et al (2001) Preoperative detection of hepatocellular carcinoma: Ferumoxides-enhanced MR imaging versus combined helical CT during arterial portography and CT hepatic arteriography. AJR Am J Roentgenol 176:475-482
7. Lim JH, Choi D, Cho SK et al (2001) Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 220:669-676
8. Elizondo G, Weissleder R, Stark DD (1990) Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology 174:797-801
9. Hundt W, Petsch R, Helmberger T et al (2000) Signal changes in liver and spleen after Endorem administration in patients with and without liver cirrhosis. Eur Radiol 10:409-416
10. Matsuo M, Kanematsu M, Kondo H et al (2001) Confluent hepatic fibrosis in cirrhosis: Ferumoxides-enhanced MR imaging findings. Abdom Imaging 26:146-148
11. Mori K, Yoshioka H, Itai Y et al (2000) Arterioportal shunts in cirrhotic patients: Evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. AJR Am J Roentgenol 175:1659-1664
12. Nakashima Y, Nakashima O, Tanaka M, Okuda K, Nakashima M, Kojiro M (2003) Portal vein invasion and intrahepatic micrometastases in small hepatocellular carcinoma by gross type. Hepatol Res 26:142-147
13. Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC (1997) Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: Optimization with a test examination and a power injector. Radiology 202:268-273
14. Ueda K, Matsui O, Kawamori Y et al (1998) Differentiation of hypervascular hepatic pseudolesions from hepatocellular carcinoma: Value of single-level dynamic CT during hepatic arteriography. J Comput Assist Tomogr 22:703-708
15. Lim JH, Choi D, Park CK, Lee WJ, Lim HK (2006) Encapsulated hepatocellular carcinoma: CT-pathologic correlations. Eur Radiol 16:2326-2333
16. Yu JS, Lee JH, Chung JJ, Kim JH, Kim KW (2008) Small hypervascular hepatocellular carcinoma: Limited value of portal and delayed phases on dynamic magnetic resonance imaging. Acta Radiol 49:735-743
17. Nakano M, Saito A, Takasaki K, Obata H, Kobayashi S (1990) A histopathologic study of early hepatocellular carcinoma: Portal tract invasion and progression to advanced hepatocellular carcinoma. Acta Hepatol Japan 31:754-762
18. International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983-993
19. Ward J, Guthrie JA, Scott DJ et al (2000) Hepatocellular carcinoma in the cirrhotic liver: Double-contrast MR imaging for diagnosis. Radiology 216:154-162
20. Pauleit D, Textor J, Bachmann R et al (2002) Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Radiology 222:73-80
21. Tang Y, Yamashita Y, Arakawa A et al (1999) Detection of hepatocellular carcinoma arising in cirrhotic livers: Comparison of gadolinium- and ferumoxides-enhanced MR imaging. AJR Am J Roentgenol 172:1547-1554
22. Matsuo M, Kanematsu M, Itoh K et al (2001) Detection of malignant hepatic tumors: Comparison of gadolinium and ferumoxides-enhanced MR imaging. AJR Am J Roentgenol 177:637-643
23. Kim YK, Kim CS, Kwak HS, Lee JM (2004) Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: Comparison with superparamagnetic iron oxide-enhanced MR imaging. J Magn Reson Imaging 20:826-837
24. Yu JS, Kim KW, Jeong MG, Lee JT, Yoo HS (2000) Nontumorous hepatic arterial-portal venous shunts: MR imaging findings. Radiology 217:750-756
25. Jeong YY, Mitchell DG, Kamishima T (2002) Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: Clinical implications. Radiology 2002 178:1327-1334
26. Vitellas KM, Tzalonikou MT, Bennett WF, Vaswani KK, Bova JG (2001) Cirrhosis: Spectrum of findings on unenhanced and dynamic gadolinium-enhanced MR imaging. Abdom Imaging 26:601-615
27. Simon G, Link TM, Wörtler K et al (2005) Detection of hepatocellular carcinoma: Comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging. Eur Radiol 15:895-903
28. Ebara M, Ohto M, Watanabe Y et al (1986) Diagnosis of small HCC: correlation of MR imaging and tumor histologic studies. Radiology 159:371-377
29. Schneider G, Grazioli L, Saini S (2006) Imaging of malignant focal liver lesions. In: Schneider G, Grazioli L, Saini S (eds) MRI of the liver, 2nd edn. Springer, Milan, pp 187-236
30. Ueda K, Matsui O, Kawamori Y et al (1998) Hypervascular hepatocellular carcinoma: Evaluation of hemodynamics with dynamic CT during hepatic arteriography. Radiology 206:161-166
31. Grazioli L, Olivetti L, Fugazzola C et al (1999) The pseudocapsule in hepatocellular carcinoma: Correlation between dynamic MR imaging and pathology. Eur Radiol 9:62-67
32. Moon JH, Ahn CM, Chung HS, Ahn SH, Park YN (2006) A case of hypervascular hyperplastic nodules in a patient with alcoholic liver cirrhosis. Yonsei Med J 47:881-886
33. Kim SR, Imoto S, Ikawa H et al (2008) Focal nodular hyperplasia-like lesion with venous washout in alcoholic liver cirrhosis. Intern Med 47:1899-1903
34. Takeshita K, Nagashima I, Frui S et al (2002) Effect of superparamagnetic iron oxide-enhanced MRI of the liver with hepatocellular carcinoma and hyperplastic nodule. J Comput Assist Tomogr 26:451-455
35. Saito K, Kotake F, Ito N et al (2005) Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: Quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci 4:1-9